Prognostic analysis indicated that esophageal cancer patients with high ZC3H18 expression had significantly reduced overall survival (OS) (P = 0.02), while a reduction in disease-free survival (DFS) was observed but did not reach statistical significance (P = 0.057) (Figure 2C). This evidence concerns the gene ZC3H18 and esophageal cancer.